Amended Safety Assessment of Parabens as Used in Cosmetics.


Journal

International journal of toxicology
ISSN: 1092-874X
Titre abrégé: Int J Toxicol
Pays: United States
ID NLM: 9708436

Informations de publication

Date de publication:
Historique:
entrez: 30 7 2020
pubmed: 30 7 2020
medline: 12 3 2021
Statut: ppublish

Résumé

The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of 21 parabens as preservatives in cosmetic products. All of these ingredients are reported to function in cosmetics as preservatives; however, 5 are reported to also function as fragrance ingredients. The Panel reviewed relevant data relating to the safety of these ingredients under the reported conditions of use in cosmetic formulations. The Panel concluded that 20 of the 21 parabens included in this report are safe in cosmetics in the present practices of use and concentration described in this safety assessment when the sum of the total parabens in any given formulation does not exceed 0.8%. However, the available data are insufficient to support a conclusion of safety for benzylparaben in cosmetics.

Identifiants

pubmed: 32723119
doi: 10.1177/1091581820925001
doi:

Substances chimiques

Cosmetics 0
Parabens 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

5S-97S

Auteurs

Priya Cherian (P)

Cosmetic Ingredient Review Scientific Analyst/Writer, Washington, DC, USA.

Jinqiu Zhu (J)

Cosmetic Ingredient Review Toxicologist, Washington, DC, USA.

Wilma F Bergfeld (WF)

Expert Panel for Cosmetic Ingredient Safety Member, Washington, DC, USA.

Donald V Belsito (DV)

Expert Panel for Cosmetic Ingredient Safety Member, Washington, DC, USA.

Ronald A Hill (RA)

Former Expert Panel for Cosmetic Ingredient Safety Member, Washington, DC, USA.

Curtis D Klaassen (CD)

Expert Panel for Cosmetic Ingredient Safety Member, Washington, DC, USA.

Daniel C Liebler (DC)

Expert Panel for Cosmetic Ingredient Safety Member, Washington, DC, USA.

James G Marks (JG)

Expert Panel for Cosmetic Ingredient Safety Member, Washington, DC, USA.

Ronald C Shank (RC)

Expert Panel for Cosmetic Ingredient Safety Member, Washington, DC, USA.

Thomas J Slaga (TJ)

Expert Panel for Cosmetic Ingredient Safety Member, Washington, DC, USA.

Paul W Snyder (PW)

Cosmetic Ingredient Review Toxicologist, Washington, DC, USA.

Bart Heldreth (B)

Cosmetic Ingredient Review Executive Director, Washington, DC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH